drugset / Trial / NCT00347360

The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial

NCT00347360

Phase 3 Completed 654 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double-blind, double-dummy, parallel group trial employing 15 cells of a 4x4 factorial design (no placebo)to compare the hypertensive effects in patients with Stage 1 and Stage 2 hypertension of carvedilol (20, 40 or 80 mg daily) alone, lisinopril (10, 20 or 40 mg daily) alone, and all combinations of the doses.

Timeline

Start
2006-07
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 20 mg
Subject Carvedilol Other / unclassified 40 mg
Subject Carvedilol Other / unclassified 80 mg
Subject LISINOPRIL ANHYDROUS Small molecule 10 mg
Subject LISINOPRIL ANHYDROUS Small molecule 20 mg
Subject LISINOPRIL ANHYDROUS Small molecule 40 mg

Indications